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Abstract
Purpose
The miniaturization of instruments has had an impact on stone management. The aims of
this study were to highlight surgeon preferences among Retrograde Intra Renal Surgery
(RIRS), Regular, Mini-, UltraMini- and Micro- Percutaneous Nephrolithotomy (PCNL) for
urolithiasis and to compare the effectiveness and safety of these techniques in a real-life
setting.
Methods
A 12-item survey regarding endourological techniques was conducted through Survey Mon-
key among attendees of the 2013 European Association of Urology Section of Urolithiasis
meeting. We asked responders to share data from the last 5 cases they performed for each
technique. Procedures were stratified according to stone size and the centres’ surgical vol-
ume. Techniques were compared in terms of effectiveness and safety. Analyses were per-
formed on the overall group and a subgroup of 1–2 cm stones.
Results
We collected data from a total of 420 procedures by 30, out of 78, urologists who received
the survey (response rate 38%): 140 RIRS, 141 Regular-PCNL (>20 Ch), 67 Mini-PCNL
(14–20 Ch), 28 UltraMini-PCNL (11–13 Ch) and 44 Micro-PCNL (4,8–8 Ch). Techniques
choice was influenced by stone size and the centre’s surgical volume. Effectiveness and
safety outcomes were influenced by stone size, independently of the technique. The stone-
free rate was significantly lower in Micro-PCNL compared to Regular-PCNL. This was not
confirmed for 1–2 cm stones. All techniques presented a lower complication rate than Regu-
lar-PCNL, with Mini-PCNL being the most protective technique compared to Regular-PCNL.
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Conclusions
Stone size seems to drive treatment choice. Miniaturized PCNL techniques are widely
employed for 1–2 cm stones, in particular in higher surgical volume centres. Mini-PCNL and
RIRS are growing in popularity for stones > 2 cm. Mini-PCNL seems to be a good compro-
mise, being the most effective and safe procedure among PCNL techniques. RIRS is char-
acterized by satisfactory stone-free and low complication rates.
Introduction
Nephrolithiasis is a common disease with a high worldwide prevalence that ranges from 7 to
13% in North America, 5–9% in Europe, and 1–5% in Asia [1]. Geography, diet, fluid intake,
genetics, climate, age, and occupation are important factors that can affect the incidence of
this disease. Kidney stone management is expensive and surgery is often the gold standard
treatment. The European Association of Urology Guidelines define External Shock Wave Lith-
otripsy (ESWL) or Endourology as the first-choice treatments for 1–2 cm kidney stones, where
the term ‘Endourology’ encompasses all Percutaneous Nephrolithotomy (PCNL) and Ureter-
orenoscopy (URS) interventions. For stones bigger than 2 cm the gold standard is PCNL treat-
ment [2]. Nowadays, the panorama of PCNL instrumentation is extremely wide and includes
Micro-PCNL with 4,8 Ch, UltraMini-PCNL (UMP) with 11–13 Ch, Mini-PCNL with 14–20
Ch, Regular-PCNL with > 20 Ch access diameters. The miniaturization of instruments has
impacted indications, as smaller tracts theoretically reduce complications such as blood loss
and renal parenchyma injury [3–4]. Retrograde Intra Renal Surgery (RIRS) is included among
the first line treatments for kidney stones between 1 and 2 cm, but could be proposed as a via-
ble alternative therapy to PCNL for stones larger than 2 cm in special groups of high-risk
patients (e.g. those with bleeding disorders, obesity, renal congenital abnormalities, or solitary
kidney) [5]. The guidelines consider each of these techniques but don’t provide specific indica-
tions for the different sized PCNL techniques and do not univocally define the best treatment
option for kidney stones, especially for calculi between 1 and 2 cm.
Purpose
The aim of our study is to highlight surgeons’ preferences among RIRS, Regular, Mini-, Ultra-
Mini- and Micro-PCNL in stone treatment in a real-life setting, based on a Survey approved
by the European Association of Urology Section of Urolithiasis (EULIS).
Moreover, we compared the effectiveness and safety of these techniques in stone treatment,
with a particular interest on the grey zone of 1–2 cm stones.
Materials and methods
We performed a Survey approved by the EULIS board in Cape Town on December 2014
regarding the employment of RIRS and regular and small sized PCNL among physicians who
attended the Copenhagen EULIS meeting in 2013. The project was carried out in three steps
using Survey Monkey and took place from February 2015 (collection of the first and second-
step results) to May 2015 (third step). This article is focused on the results from the third step.
An introductory email was sent to all participants, describing the study and providing the link
to the online questionnaire. Participation was voluntary. The first two steps aimed to delineate
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the departments’ profiles in terms of instrument availability and performed techniques, and to
collect experts’ personal opinions on RIRS and regular and small size PCNL.
In the third step responders were asked to report the number of procedures performed dur-
ing the previous year and to share information regarding the last 5 cases treated in their centres
with each of the techniques under study for which they had at least one-month of follow-up.
They were asked to report data concerning different pre-, intra- and post-operative items.
Twelve of these items were common for all procedures: 5 were related to patient, stone or
operation characteristics (i.e. age, sex, comorbidities, stone size and exit strategy), 2 were con-
sidered effectiveness outcomes (i.e. one month stone-free status and need for retreatment) and 5
were safety outcomes (i.e. operation time, Hb drop, need for transfusions, hospital stay duration
and complications according to the Clavien/Dindo scale). Stone size was defined as the maxi-
mum stone diameter. In cases of multiple stones the cumulative maximum stone diameter was
used. Stones were categorized in three groups according to their size (i.e. < 1 cm, 1–2 cm, > 2
cm). Operation time was dichotomized by surgeries lasting� 60 minutes and those lasting
longer. Stone free status was defined as the total absence of residual fragments at the 1-month
follow-up evaluation. The imaging modality used to determine stone presence/absence
was dependent on each centre’s local protocol. The questionnaires we sent to collect data on
RIRS and PCNL procedures are available in the supporting information files (S1 and S2 Figs,
respectively).
Procedures were stratified according to stone size and each centre’s surgical volume
(>/<50 PCNL procedures performed during the previous year).
We explored whether or not effectiveness and safety outcomes differed in relation to stone
size, using the Chi-squared test for qualitative outcomes and linear regression analysis for
quantitative outcomes, previously log transformed if appropriate (i.e. hospital stay and haemo-
globin drop). Effectiveness and safety outcomes for the different techniques were compared
using multiple regression models (logistic for categorical outcomes and linear for quantitative
outcomes) after correction for stone size, age and gender. The same analyses were also per-
formed on a subgroup of 1–2 cm stones in order to analyse a more homogeneous group in
terms of number of procedures. Statistical analyses were performed with the Stata 10 package
considering statistical significance for P values< 0.05.
This study protocol was reviewed and approved by the ethics committee of the University
of Milan and all clinical investigations were conducted according to the principles expressed
in the Declaration of Helsinki. Every patient (parents if minor or guardians if incompetent)
signed a written informed consent for his/her clinical information to be used and shared for
research purposes.
Results
We sent the first and second step questionnaires to 360 people and obtained a 24% response
rate (88 responders). Seventy-eight physicians agreed to receive the third step questionnaire
and 38% of these (30 responders) shared data from their recent procedures using each tech-
nique. Not all responders shared 5 cases for each technique. We collected a total of 420 proce-
dures: 140 RIRS from 28 centres, 141 Regular PCNL (>20 Ch) from 27 centres, 67 Mini-
PCNL (14–20 Ch) from 15 centres, 28 UMP (11–13 Ch) from 7 centres and 44 Micro-PCNL
(4,8–8 Ch) from 8 centres. The 420 procedures were performed on an equal number of
patients. The sample population had median age of 51 years (2–89) with a slight prevalence of
males (57.86%). The techniques performed by the single centres were stratified according to
their surgical volume as shown in Table 1.
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Responders reported statistically significant differences in the chosen technique in relation
to stone size (Table 2).
As shown in Table 3, the effectiveness and safety outcomes were also influenced by stone
size, independently of the technique used.
The results of the multiple regression analysis assessing whether or not effectiveness out-
comes are influenced by the chosen technique (on all procedures, N = 420 and on procedures
for 1–2 cm stones, N = 172) are reported in Table 4. The stone free rate (SFR) was significantly
lower in patients treated with Micro-PCNL compared to Regular PCNL, when considering
procedures performed for all stone sizes (OR 0.36; P = 0.019).
The distribution of safety outcomes in relation to the different techniques and the results of
the multiple regression analysis exploring how the outcomes were influenced by the chosen
technique (on all procedures N = 420 and on procedures for 1–2 cm stones N = 172) are
reported in Table 5. All considered techniques (i.e. Mini-PCNL, UMP, Micro-PCNL and
RIRS) presented a lower complication rate than Regular-PCNL, with Mini-PCNL being the
most protective technique compared to Regular-PCNL. The total number of transfusions
reported was 17: fourteen (82.35%) in patients undergoing Regular-PCNL (3 of which for 1–2
cm stones); one (5.88%) in a patient undergoing Mini-PCNL, one (5.88%) in a patient under-
going UMP and one (5.88%) in a patient undergoing RIRS.
Table 1. Stratification of the procedures according to centres’ surgical volume.
Centres surgical
volume
Centres
n.
Centres performing Regular-
PCNL n. (%)�
Centres performing Mini-
PCNL n. (%)�
Centres performing UMP
n. (%)�
Centres performing Micro-
PCNL n. (%)�
< 50 PCNL/year 17 15/17 (88%) 6/17 (35%) 2/17 (12%) 4/17 (23%)
> 50 PCNL/year 13 12/13 (92%) 9/13 (69%) 5/13 (38%) 4/13 (31%)
�Numbers and percentages of centres which performed at least 1 procedure are reported for each technique in the 2 groups.
https://doi.org/10.1371/journal.pone.0205159.t001
Table 2. Comparison of the chosen techniques according to stone size. Chi-squared test results are reported.
Stone size Regular PCNL n. (%) Mini-PCNL n. (%) UMP n. (%) Micro-PCNL n. (%) RIRS n. (%) Tot n. (%) P-value
� 1 cm 3 (5%) 1 (2%) 2 (3%) 7 (11%) 49 (79%) 62 (100%) <0.0001
1–2 cm 26 (15%) 30 (17%) 24 (14%) 29 (17%) 63 (37%) 172 (100%)
> 2 cm 112 (60%) 36 (20%) 2 (1%) 8 (4%) 28 (15%) 186 (100%)
https://doi.org/10.1371/journal.pone.0205159.t002
Table 3. Comparison of effectiveness and safety outcomes among stones of different sizes. For categorical variables the number of outcomes, percentages and Chi-
squared test results are reported, while for quantitative outcomes (�) medians, ranges and linear regression results are reported.
Outcome � 1 cm 1–2 cm > 2 cm Total P value
One month stone free n. (%) 58 (93.55%) 141 (82.46%) 127 (68.28%) 326 (77.80%) < 0.0001
Second procedure needed n. (%) 2 (3.23%) 12 (7.06%) 35 (18.82%) 49 (11.72%) < 0.0001
Operative time (> 60 min) n. (%) 53 (85.48%) 91 (55.15%) 57 (30.65%) 201 (48.67%) < 0.0001
Hb drop�
Median (interquartile range)
0 (0–4.2) 0.4 (0–3.9) 1.2 (0–6.8) 0.6 (0–6.8) Coef. 0.46
(CI 0.29–0.63)
< 0.0001
Transfusion needed n. (%) 1 (1.64%) 3 (1.78%) 13 (6.99%) 17 (4.09%) 0.027
Clavien/Dindo scale�1 n. (%) 60 (96.77%) 158 (91.86%) 158 (85.41%) 376 (89.74%) 0.019
Hospital stay �
Median (interquartile range)
2 (0–10) 2 (0–11) 4 (0–30) 3 (0–30) Coef. 0.36
(CI 0.26–0.46)
< 0.0001
https://doi.org/10.1371/journal.pone.0205159.t003
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Discussion
This article is based on the first survey within the EULIS group. The main goal in stone treat-
ment is to achieve the highest effectiveness with the lowest morbidity. Over recent years, many
authors have made comparisons among the different available techniques but still no clear and
univocal indications have been delineated, and a wide heterogeneity exists in the application of
the single procedures [6]. While only a randomized controlled trial (RCT) could completely
resolve this issue, our study outlines the real-life clinical practice among EULIS members.
Techniques application
Our data show that the techniques are employed differently according to stone size. In particu-
lar, Regular-PCNL is the most used technique for stones> 2 cm, followed by Mini-PCNL and
RIRS. For stones < 1 cm, RIRS is widely applied. In cases of 1–2 cm stones the indication is
less univocal with a slight prevalence of PCNL (evenly distributed among the different tract
size options) over RIRS. The distribution of the employed techniques is not uniform among
the respondent centres. In particular, while RIRS and Regular-PCNL are performed by almost
all of the responders, Mini-PCNL is practiced by only half of them, and UMP and Micro-
PCNL, as expected, are the least performed techniques. The choice of technique also seems
to be related to the centres’ surgical volume. Specifically, centres performing more than 50
PCNL/year more often apply miniaturized PCNL techniques (including Mini-PCNL, UMP
and Micro-PCNL) than centres performing less than 50 PCNL/year. This could be explained
not only by the more robust surgical experience but also by the availability of mini invasive
instruments and the related costs.
Effectiveness
Background. S. Mishra et al. demonstrated that Mini- and Regular-PCNL can achieve
equally effective results in terms of SFR for 1–2 cm stones (96% and 100% respectively, P
value = 0.49) [7]. K. Wilhelm et al. reported comparable results for UMP and RIRS in 10–35
mm stones (SFR 92% and 96% respectively, P value = 0.561) [8]. Other studies have obtained
comparable stone clearance rates with micro-PCNL and RIRS for stones up to 1,5 cm (97.1%
Table 4. Comparison of effectiveness outcomes across different techniques (Regular-PCNL considered as reference) for all procedures reported by the responders
and for procedures performed on 1–2 cm stones. The table presents the Odds Ratio (OR) adjusted for stone size, age, and gender.
Outcome Regular-PCNL Mini-PCNL UltraMini-PCNL Micro-PCNL RIRS
% OR
(95%
CI)
% OR
(95% CI)
P-value % OR
(95% CI)
P-value % OR
(95% CI)
P-value % OR
(95% CI)
P-value
All procedures (N = 420)
One month stone
free
73.1% Ref 85.1% (0.78–
3.79)
1.72
(0.78–
3.79)
NS 82.1% 0.60
(0.19–
1.87)
NS 70.5% 0.36
(0.15–
0.85)
0.019 80.6% 0.62
(0.32–
1.21)
NS
Second procedure
needed
20% Ref 3.0% 0.15
(0.03–
0.66)
0.012 7.1% 0.69
(0.14–
3.39)
NS 4.6% 0.37
(0.08–
1.73)
NS 10.8% 1.10
(0.49–
2.4)
NS
Procedures for 1–2 cm stones (N = 172)
One month stone
free
88.5% Ref 93.3% 1.51
(0.23–
10.1)
NS 83.3% 0.61
(0.12–
3.20)
NS 69.0% 0.27
(0.06–
1.16)
NS 80.3% 0.51
(0.13–
1.99)
NS
Second procedure
needed
12.0% Ref 0.0% - - 4.2% 0.31
(0.03–
3.27)
NS 6.9% 0.54
(0.08–
3.54)
NS 9.9% 0.81
(0.19–
3.54)
NS
https://doi.org/10.1371/journal.pone.0205159.t004
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and 94.1% respectively, P value = 1.0 by R.B. Sabnis et al.; 83.3% and 86.7% respectively, by
Kandemir et al.) [9–10]. A review by De et al. reported that minimally invasive percutaneous
procedures, including Mini- and Micro-PCNL, could provide higher stone-free rates than
RIRS [11]. Nevertheless, many studies in the literature report SFRs over 90% for RIRS per-
formed for stones larger than 2 cm, and thus consider it an attractive alternative to PCNL [12–
13]. Furthermore, Micro-PCNL has been described as an adequate treatment method for
Table 5. Comparison of safety outcomes across different techniques (Regular-PCNL considered as reference) for all procedures reported by the responders and for
procedures performed on 1–2 cm stones. The table presents the Odds Ratio (OR) for binary outcomes and regression coefficients (Coef) for multiple outcomes, adjusted
for stone size, age and gender.
Outcome Regular-PCNL Mini-PCNL UltraMini-PCNL Micro-PCNL RIRS
% or
Median
with
range
(95%
CI)
% or
Median
with
range
OR or
Coef
(95% CI)
P-
value
% or
Median
with
range
OR or
Coef
(95% CI)
P-
value
% or
Median
with
range
OR or
Coef
(95% CI)
P-value % or
Median
with
range
OR or
Coef
(95% CI)
P-value
All procedures (N = 420)
Operative time
(>60 min)
58.2% Ref 57.81% OR 1.44
(0.75–
2.75)
NS 33.3% OR 1.16
(0.42–
3.20)
NS 70.5% OR 5.98
(2.51–
14.24)
<0.001 38.6% OR 1.61
(0.86–3)
NS
Complications
(Clavien/Dindo
Scale)
0
55.3% Ref 77.6% OR 0.35
(0.18–
0.67)
0.002 78.6% OR 0.42
(0.15–
1.14)
NS 70.5% OR 0.59
(0.27–
1.25)
NS 69.5% OR 0.53
(0.30–
0.93)
0.027
1 24.8% Ref 14.9% 10.7% 18.2% 28.4%
2 14.2% Ref 6.0% 10.7% 11.4% 0.7%
3a 4.3% Ref 0.0% 0.0% 0.0% 1.4%
3b 1.4% Ref 0.0% 0.0% 0.0% 0,0%
4a 0.0% Ref 1.5% 0.0% 0.0% 0.0%
Hb drop 1.6 (0–
6.8)
Ref 1 (0–4) Coef.
-0.33
(-0.62-
-0.08)
0.018 0.3 (0–
2.5)
Coef.
-0.67
(-1.1-
-0.21)
0.004 0.4 (0–3) Coef.
-0.69
(-1.1-
-0.33)
<0.001 0 (0–4.2) Coef.
-1.15
(-1.5-
-0.84)
<0.001
Hospital stay 4 (1–30) Ref 3 (1–24) Coef.
-0.28
(-0.48-
-0.079)
0.006 2 (0–8) Coef.
-0.44
(-0.75–
0.138)
0.005 2 (1–6) Coef.
-0.80
(-1.02–
0.52)
<0.001 2 (0–19) Coef.
-0.51
(-0.71-
-0.32)
<0.001
Procedures for 1–2 cm stones (N = 172)
Operative time
(>60 min)
26.92% Ref 37.04% OR 1.5
(0.46–
4.88)
NS 35.00% OR 1.66
(0.46–
6.11)
NS 75.86% OR 8.73
(2.57–
29.69)
0.001 43.55% OR 2.09
(0.76–
5.74)
NS
Complications
(Clavien/dindo
Scale)
0
34.62% Ref 83.33% OR 0.12
(0.04–
0.42)
0.001 79.17% OR 0.19
(0.05–
0.64)
0.008 68.97% OR 0.29
(0.1–
0.84)
0.022 72.58% OR 0.21
(0.08–
0.51)
0.001
1 46.15% Ref 10,0% 12.50% 17.24% 25.81%
2 15.38% Ref 6.67% 8.33% 13.79% 0,0%
3a 3.85% Ref 0.0% 0.0% 0.0% 1.61%
Hb drop 1.7 (0–
3.9)
Ref 0.8 (0–
3.1)
Coef.
-0.40
(-0.92–
0.13)
NS 0.5 (0–
2.5)
Coef.
-0.70
(-1.3-
-0.1)
0.020 0.5 (0–3) Coef.
-0.61
(-1.1-
-0.08)
0.025 0 (0–2.7) Coef.
-1.45
(-2.0-
-0.9)
<0.001
Hospital stay 4 (1–11) Ref 3 (1–8) Coef.
-0.41
(-0.75-
-0.07)
0.020 2 (0–8) Coef.
-0.48
(-0.85-
-0.1)
0.013 2 (1–6) Coef.
-0.80
(-1.14-
-0.46)
<0.001 2 (0–11) Coef.
-0.60
(-0.90-
-0.30)
<0.001
https://doi.org/10.1371/journal.pone.0205159.t005
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peculiar indications such as solitary renal stones with a volume <1 000 mm3 and low density
(HU) [14].
Therefore, great discrepancies exist in the reported outcomes of the available procedures.
Moreover, the imaging modality and the timing of stone clearance assessment are variable in
the cited studies, with some authors using X-ray KUB at 1 or 3 months [7, 9], others using
endoscopic inspection and immediate postoperative ultrasound or low-dose CT 4–8 weeks
after the procedure [8] and still others using non-contrast spiral CT at 3 months [10]. This ren-
ders the comparisons between techniques even less reliable.
The lack of consensus on the best follow-up imaging modality was probably reflected in the
series we analyzed, in which different local protocols were adopted.
Overall analysis. In our series, considering all performed procedures, no significant dif-
ferences were observed in terms of SFR between Regular-PCNL and Mini-PCNL, UMP and
RIRS, even if Mini-PCNL seemed to be more effective than UMP and RIRS according to the
higher odds ratio. Moreover, Mini-PCNL was the only technique studied that resulted in a sig-
nificantly lower need for second procedures. Micro-PCNL, rather, presented a significantly
lower SFR than Regular-PCNL; nevertheless, the retreatment rate after this technique didn’t
differ in a statistically significant way from the other techniques, suggesting that the clinical
outcomes may be satisfactory enough to not require a second operation.
1–2 cm stones group. In the 1–2 cm stone group, no statistically significant differences
were observed among any of the techniques with respect to Regular-PCNL. However, the
results were similar to those described for the total group, with the best outcomes being
observed for Mini-PCNL and the lowest SFR for Micro-PCNL.
Safety
Background. As already stated in the literature, reductions in both haemoglobin loss and
hospital stay are obtained by reducing the invasiveness of the procedure [11]; S. Mishra et al.
demonstrated that Mini-PCNL for 1–2 cm stones is limited by longer operative times than
standard-PCNL but is characterized by significantly less bleeding, shorter hospital stays and a
similar safety profile [7].
K. Wilhelm et al., in a comparison of UMP and RIRS for 10–35 mm stones, demonstrated
that operating times and hospital stays were significantly longer in the UMP group. No patient
in their study required a blood transfusion [8]. R.B. Sabnis et al., after randomizing patients to
either RIRS or Micro-PCNL for stones< 1.5 cm, demonstrated that Micro-PCNL was associ-
ated with greater haemoglobin loss, increased pain and more analgesic requirements, while
RIRS was associated with a higher requirement for JJ stenting [9]. A. Kandemir et al., compar-
ing the same techniques for lower pole stones up to 1.5 cm, found similar complication rates
but longer scopy times and hospital stays associated with Micro-PCNL [10].
A.Yamaguchi et al., in their study of 5537 patients who underwent PCNL, observed that
bleeding and transfusions tended to increase with an increasing size of the access sheath (18
Ch to 34 Ch) [15].
De et al. found that PCNL is related to higher complication rates, blood loss and longer
lengths of stay than RIRS, with no differences in surgical time and secondary procedures. Min-
imally invasive percutaneous procedures, including Mini- and Micro-PCNL, were also found
to be related to added morbidity and longer hospital stays than RIRS for stones<2 cm [11].
Overall analysis. In the overall group, our results confirmed that each of the small sized
PCNL techniques and RIRS produced less haemoglobin loss and shorter hospital stays than
Regular-PCNL. With regard to complications, Mini-PCNL was revealed to be the safest
among the PCNL techniques. UMP and Micro-PCNL also appeared to be safe procedures, but
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didn’t result in statistically significant differences, probably due to the smaller number of
patients treated with these techniques in our series. RIRS also, and in line with the literature
[9,16], was related to significantly lower complication rates than Regular-PCNL. Operative
times were comparable to those of Regular-PCNL for all techniques except Micro-PCNL,
which appeared to be the most time-consuming procedure.
1–2 cm stone group. Safety results within the 1–2 cm stone group were similar to those
of the overall group. Haemoglobin drop and hospital stay progressively decreased with the
reduction of invasiveness. For all techniques, high-grade (Clavien�2) complication rates were
lower than they were for Regular-PCNL. Micro-PCNL appeared to be the most time-consum-
ing technique in this group as well.
Limitations
One major limitation of this study, intrinsic to the nature of surveys, is the low response rate.
This was probably due to the lack of ready availability in all centres to the quested data.
Another limitation of the present study is represented by its multicentre retrospective
design, which may have led to a misestimation of some of the outcomes. In particular, the
stone free status was assessed with different imaging modalities in accordance with the individ-
ual centres’ local protocols, which were not investigated in our survey. This reduces the com-
parability of the results. Nevertheless, the retreatment rate could be considered as a suitable
surrogate for the effectiveness of the procedures.
One further limitation is the small number of miniaturized PCNL procedures reported.
This is due, as explained above, to the infrequent application of these techniques in lower sur-
gical volume centres.
We decided to keep the questionnaire as concise and short as possible to maximize the pos-
sibility of obtaining responses, only recording fundamental variables. This may have caused us
to overlook some characteristics such as stone location and number of stones that could have
been useful for the comparison among techniques.
Conclusions
Stone size seems to be an important factor driving treatment choice. Miniaturized PCNL tech-
niques are widely applied in the treatment of 1–2 cm stones, in particular in higher surgical
volume centres. Mini-PCNL and RIRS are gaining in popularity also in the treatment of
stones> 2 cm.
The miniaturization of PCNL appears to result in a safer procedure without compromising
effectiveness. In particular Mini-PCNL, with accesses ranging from 14 to 20 Ch, seems to be a
good compromise, being the most effective and the safest procedure among the PCNL tech-
niques both in the overall group as well as the 1–2 cm stones group. Micro-PCNL appears to
be the most time-consuming technique and probably requires highly selected indications.
RIRS continues to be a procedure characterized by satisfactory stone-free rates and low com-
plication rates. Nevertheless, considering the limitations of our survey and its retrospective
and multicentre design, we cannot draw firm conclusions on the best technique to treat kidney
stones. Future RCTs would be the best option for shedding more light on the subject.
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